Our | Products


Relotib 150mg





THERAPEUTIC AREA: Oncology / Hematology
ACTIVE PRINCIPLE: Erlotinib
PRESENTATION: 150 mg x 30 coated tablets
INDICATION:

  • Non-Small Cell Lung Cancer
  • Pancreatic Cancer